中国医科大学学报

中国医科大学学报
  • 中文核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
  • BA、CA收录

中国医科大学学报 ›› 2018, Vol. 47 ›› Issue (5): 448-453.doi: 10.12007/j.issn.0258-4646.2018.05.015

• 论著 • 上一篇    下一篇

癌组织中CD45RO表达水平与肺腺癌患者临床病理特征及生存率的关联分析

俞达辉, 吴道立, 袁冲, 褚文炎   

  1. 余姚市人民医院心胸外科, 浙江 余姚 315400
  • 收稿日期:2017-04-20 出版日期:2018-05-30 发布日期:2018-04-27
  • 通讯作者: 褚文炎 E-mail:chuwenyan@163.com
  • 作者简介:俞达辉(1981-),男,主治医师,硕士.

Correlation of Tissue CD45RO with the Clinicopathological Properties and Prognosis in Surgical Patients with Lung Adenocarcinoma

YU Dahui, WU Daoli, YUAN Chong, CHU Wenyan   

  1. Department of Cardiothoracic Surgery, Yuyao People's Hospital, Yuyao 315400, China
  • Received:2017-04-20 Online:2018-05-30 Published:2018-04-27

摘要: 目的 评估肿瘤组织CD45RO表达水平与肺腺癌手术患者的临床病理参数及预后的相关性。方法 选取121例进行手术的肺腺癌患者,采集肿瘤组织和癌旁组织样本。采用anti-CD45RO抗体进行免疫组织化学染色检测CD45RO表达水平,计算染色强度分数和染色面积分数的乘积得到总表达评分,并分为高、中和低表达。结果 相对于癌旁组织,CD45RO在肺腺癌组织中高表达;肿瘤组织CD45RO表达水平与肿瘤大小、淋巴结转移呈负相关;Kaplan-Meier (K-M)曲线显示,肺腺癌组织中的CD45RO表达水平越高,无病生存期(DFS)和总体生存期(OS)越长;多因素COX回归发现,肺腺癌组织CD45RO表达量能独立预测良好的DFS,然而,低分化和淋巴结转移均能独立预测不良的DFS;肺腺癌组织CD45RO表达量是较长OS的独立预测因素,而低分化、淋巴转移及远端转移均是OS的独立危险因素。结论 肿瘤组织中CD45RO的表达水平可作为新的、可靠的生物标记物,用于评估肺腺癌手术患者的临床病理特征和预后情况。

关键词: 肺腺癌组织, CD45RO, 临床病理特征, 预后, 肺腺癌手术患者

Abstract: Objective To evaluate the association between tumor tissue CD45RO expression and the clinicopathological properties and prognoses in surgical patients with lung adenocarcinoma (LAC).Methods One hundred and twenty-one patients with LAC were recruited for the study. LAC tissues and paired adjacent LAC tissue samples were collected. CD45RO expression was evaluated based on immunohistochemistry.Results CD45RO expression was higher in tumor tissue samples than in paired adjacent LAC tissue samples. Tumor tissue CD45RO expression was positively associated with tumor size but was negatively associated with lymph node metastasis (LYM). Kaplan-Meier curves revealed that high tumor tissue CD45RO expression was correlated with better disease-free survival (DFS) and overall survival (OS) compared to those of low tumor tissue CD45RO expression. Univariate COX regression indicated that high tumor tissue CD45RO expression predicted prolonged DFS,while poor differentiation,LYM,and tumor-node-metastasis (TNM) stage predicted worse DFS. Multivariate COX regression revealed that high tumor tissue CD45RO expression was an independent protective factor of DFS,while poor differentiation and LYM acted as independent risk factors of DFS. Furthermore,univariate analysis indicated that high tumor tissue CD45RO expression predicted prolonged OS,while poor differentiation,LYM,distant metastases,and TNM stage predicted worse OS. Multivariate analysis revealed that poor differentiation,LYM,and distant metastases acted as independent risk factors of shorter OS.Conclusion CD45RO expression could serve as a novel and convincing prognostic biomarker in surgical patients with LAC.

Key words: tumor tissue, CD45RO, clinicopathological, prognosis, lung adenocarcinoma

中图分类号: 

  • R734.2
[1] CANCER GENOME ATLAS RESEARCH N. Comprehensive molecular profiling of lung adenocarcinoma[J]. Nature,2014,511(7511):543-550. DOI:10.1038/nature13385.
[2] HERBST RS,HEYMACH JV,LIPPMAN SM. Lung cancer[J]. N Engl J Med,2008,359(13):1367-1380. DOI:10.1056/NEJMra0802714.
[3] ANDERSEN R,DONIA M,WESTERGAARD MC,et al. Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma[J]. Hum Vaccin Immunother,2015,11(12):2790-2795. DOI:10.1080/21645515.2015.1075106.
[4] 李满意,刘济生,周慧,等. CD45RO在喉鳞状细胞癌中的表达及临床意义[J]. 临床耳鼻咽喉头颈外科杂志,2014,28(6):373-375,380. DOI:10.13201/j.issn.1001-1781.2014.06.005.
[5] HALL M,LIU H,MALAFA M,et al. Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors[J]. J Immunother Cancer,2016,4(1):61. DOI:10.1186/s40425-016-0164-7.
[6] OSINSKY S,KOVELSKAYA A,BUBNOVSKAYA L,et al. CD8 and CD45RO T lymphocytes in bone marrow of gastric cancer patients:correlation with disseminated tumor cells and disease outcome[J]. Exp Oncol,2015,37(1):48-52.
[7] POLLARD JW. Tumour-educated macrophages promote tumour progression and metastasis[J]. Nat Rev Cancer,2004,4(1):71-78. DOI:10.1038/nrc1256.
[8] SALLUSTO F,GEGINAT J,LANZAVECCHIA A. Central memory and effector memory T cell subsets:function,generation,and maintenance[J]. Annu Rev Immunol,2004,22(1):745-763. DOI:10.1146/annurev.immunol.22.012703.104702.
[9] RANGEL R,ROCHA L,RAMIREZ JL,et al. Generation of memory CD4+,CD8+,CD45RO+ and CD16-lymphocytes activated with IL-2, INF-gamma,and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture[J]. Eur Cytokine Netw,1995,6(3):195-202.
[10] PENG RQ,WU XJ,DING Y,et al. Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stageⅢB colon cancer[J]. BMC Cancer,2010,10:496. DOI:10.1186/1471-2407-10-496.
[11] YAJIMA R,YAJIMA T,FUJⅡ T,et al. Tumor-infiltrating CD45RO (+) memory cells are associated with a favorable prognosis breast cancer[J]. Breast Cancer,2016,23(4):668-674. DOI:10.1007/s12282-015-0622-y.
[12] HOTTA K,SHO M,FUJIMOTO K,et al. Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma[J]. Br J Cancer, 2011,105(8):1191-1196. DOI:10.1038/bjc.2011.368.
[13] KOELZER VH,LUGLI A,DAWSON H,et al. CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival[J]. J Transl Med,2014,12:81. DOI:10.1186/1479-5876-12-81.
[14] SALGADO R,DENKERT C,DEMARIA S,et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer:recommendations by an international TILs working group 2014[J]. Ann Oncol, 2015,26(2):259-271. DOI:10.1093/annonc/mdu450.
[15] WAKATSUKI K,SHO M,YAMATO I,et al. Clinical impact of tumor-infiltrating CD45RO (+) memory T cells on human gastric cancer[J]. Oncol Rep,2013,29(5):1756-1762. DOI:10.3892/or.2013.2302.
[1] 徐国帅, 蔡相军, 陈江波, 吕庆, 刘洪涛. AEG-1和CHD5在胃癌中的表达及其临床意义[J]. 中国医科大学学报, 2018, 47(9): 797-802.
[2] 马艳梅, 常箫匀. 结直肠癌患者围手术期肠内外联合营养支持与预后的关系[J]. 中国医科大学学报, 2018, 47(7): 604-608.
[3] 姜文娟, 刘文静, 李晓曦, 沈雪莉. 1例急性原发性胼胝体变性病例的回顾分析[J]. 中国医科大学学报, 2018, 47(7): 657-659.
[4] 芦婷婷, 王治博. 术前血浆纤维蛋白原和D-二聚体水平与结直肠癌预后的关系[J]. 中国医科大学学报, 2018, 47(6): 513-518.
[5] 武佳科, 田春阳, 何东旭, 宋佳, 于彤彤, 孙志军, 孙兆青. 休克指数对行经皮冠状动脉介入治疗的急性心肌梗死患者长期预后的预测价值[J]. 中国医科大学学报, 2018, 47(6): 522-526.
[6] 刘晓, 王彤, 蒋怡芳, 王媛. 病原学阳性与阴性的医院获得性肺炎患者临床特征及预后比较[J]. 中国医科大学学报, 2018, 47(5): 406-410,414.
[7] 邵洋, 胡延平, 刘勇. 慢性淋巴细胞白血病患者长链非编码RNA RP5-180C18.1的表达及其预后评价作用[J]. 中国医科大学学报, 2018, 47(4): 341-345.
[8] 张苏宁, 刘宗昂. 小细胞肺癌中DBC1的表达及预后相关性研究[J]. 中国医科大学学报, 2018, 47(3): 222-225.
[9] 王鸾, 蔡雪, 赵敏. 急性百草枯中毒死亡危险因素分析[J]. 中国医科大学学报, 2018, 47(3): 237-239,243.
[10] 李蕙伊, 刘畅, 赵洋子, 曾仁庆, 甘淼, 王涛, 于诗源, 崇巍. 急诊科成人创伤患者院内死亡危险因素分析[J]. 中国医科大学学报, 2018, 47(2): 128-131.
[11] 赵雪峰, 赵美兰, 许广大. TMPRSS4在胃癌中的表达及其临床意义[J]. 中国医科大学学报, 2018, 47(11): 969-974.
[12] 赵轲, 张永建, 刘奇, 徐迪, 陈宝钧. miR-107与非小细胞肺癌的临床病理特征及预后的关联[J]. 中国医科大学学报, 2018, 47(10): 933-938.
[13] 裘敬平, 党军, 蔡峰, 李光. 基于病史、体征、血常规的食管癌预后评分系统的初步构建[J]. 中国医科大学学报, 2018, 47(1): 36-41.
[14] 唐津天 ,王伯庆 ,唐泽天 ,佟庆 ,薛峰 ,徐林 ,易超 ,晏冬. 循环 miR-106a/b 表达水平在肝细胞癌的诊断及预后中的作用[J]. 中国医科大学学报, 2017, 46(9): 830-835.
[15] 陈志岐,刘志宇,戴志红,王梁. 阴茎恶性黑色素瘤 1 例病例报告并文献复习[J]. 中国医科大学学报, 2017, 46(8): 763-765.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!

中国医科大学学报版权所有©2018

未经允许,严禁擅自转载本站图文资料

地址:中国 沈阳市沈北新区蒲河路77号 110122

辽ICP备05014850

JOURNAL OF CHINA MEDICAL UNIVERSITY

ADDRESS: NO.77 PUHE ROAD

SHENYANG NORTH NEW AREA, SHENYANG

LIAONING PROVINCE, P.R. CHINA